FIELD: medicine.
SUBSTANCE: the present innovation deals with obtaining a preparation for mesotherapy to be applied for correcting age-induced alterations of facial skin at aging. It has been suggested the method to isolate human allogenic fibroblasts for their intradermal injection to the patient. Isolation of allogenic fibroblasts should be carried out of neonatal's umbilical cord. It has been suggested the method for isolating a patient's own autologous fibroblasts to be mixed with allogenic fibroblasts from neonatal's umbilical cord. The suggested preparation for mesotherapy contains allogenic fibroblasts obtained out of neonatal's umbilical cord. The preparation for mesotherapy has been suggested that contains the mixture of allogenic fibroblasts obtained out of neonatal's umbilical cord, and autologous fibroblasts, out of a patient's own skin. The innovation enables to improve the quality of the obtained preparation and provides enhanced rejuvenation effect.
EFFECT: higher efficiency.
5 cl, 4 dwg, 2 ex, 1 tbl
